These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29975972)

  • 21. Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression.
    Schatzberg AF; Kraemer HC
    Biol Psychiatry; 2000 Apr; 47(8):736-44. PubMed ID: 10773182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
    Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
    Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials.
    Iovieno N; Tedeschini E; Ameral VE; Rigatelli M; Papakostas GI
    Int Clin Psychopharmacol; 2011 Mar; 26(2):69-74. PubMed ID: 20962663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Salagre E; Fernandes BS; Dodd S; Brownstein DJ; Berk M
    J Affect Disord; 2016 Aug; 200():235-42. PubMed ID: 27148902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2012 Apr; 66(4):356-68. PubMed ID: 22284853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.
    Mahableshwarkar AR; Jacobsen PL; Chen Y
    Curr Med Res Opin; 2013 Mar; 29(3):217-26. PubMed ID: 23252878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
    Emslie GJ; Ryan ND; Wagner KD
    J Clin Psychiatry; 2005; 66 Suppl 7():14-20. PubMed ID: 16124837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: a meta-analysis.
    Tedeschini E; Fava M; Goodness TM; Papakostas GI
    Eur Neuropsychopharmacol; 2010 Aug; 20(8):562-7. PubMed ID: 20219330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
    Weisler RH; Montgomery SA; Earley WR; Szamosi J; Lazarus A
    Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.
    Reeves H; Batra S; May RS; Zhang R; Dahl DC; Li X
    J Clin Psychiatry; 2008 Aug; 69(8):1228-1236. PubMed ID: 18681749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review.
    Lee Y; Rosenblat JD; Lee J; Carmona NE; Subramaniapillai M; Shekotikhina M; Mansur RB; Brietzke E; Lee JH; Ho RC; Yim SJ; McIntyre RS
    J Affect Disord; 2018 Feb; 227():406-415. PubMed ID: 29154157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP).
    Nagler EV; Webster AC; Vanholder R; Zoccali C
    Nephrol Dial Transplant; 2012 Oct; 27(10):3736-45. PubMed ID: 22859791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Acute-Phase Treatment With Antidepressants, 8 Weeks and Beyond: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials.
    Henssler J; Kurschus M; Franklin J; Bschor T; Baethge C
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 28068463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Tran P; Skolnick P; Czobor P; Huang NY; Bradshaw M; McKinney A; Fava M
    J Psychiatr Res; 2012 Jan; 46(1):64-71. PubMed ID: 21925682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
    Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH
    J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the frequency of follow-up assessments affect clinical trial outcome? A meta-analysis and meta-regression of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Levkovitz Y; Ameral VE; Papakostas GI
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):289-96. PubMed ID: 21557881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.